IEEM Texas Health Presbyterian Hospital Dallas
Dallas, Texas, 75231, United States
Location status: Recruiting
Location contact
Courtney Kirby, RN
CONTACT
Craig Crandall, PhD
PRINCIPAL_INVESTIGATOR
Taysom Wallace, MS
CONTACT
NCT Number: NCT06582680
This study will test the hypothesis that the drugs propranolol and metoprolol will result in greater increases in core body temperature during 3 hours of extreme heat exposure in older adults.
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Phase 4
Dallas, Texas, 75231, United States
Location status: Recruiting
Courtney Kirby, RN
CONTACT
Craig Crandall, PhD
PRINCIPAL_INVESTIGATOR
Taysom Wallace, MS
CONTACT
Older individuals are more likely to die or become ill during heat waves. During the 1995 Chicago heat wave, there was 35% increase in hospital admissions for individuals older than 65 years of age. Moreover, adults over the age of 65 have a heat-related death rate that is more than double any other age group. Therefore, with an increasing elderly population that is expected to rise by 60% (to 78 million) by 2035, the causes of this excess mortality must be understood to better protect the ageing United States population. It is notable that selective and non-selective beta blocker drugs are commonly prescribed to older individuals with cardiovascular diseases. In younger individuals exposed to a heat stress, beta blocker administration reduced whole-body sweat rate and skin blood flow responses resulting in greater increases in core body temperature. Notably, nothing is known regarding the effects of beta blockers on thermoregulatory responses during heat exposure in older individuals.
This project will evaluate core body temperature responses to selective and non-selective beta blocker drugs during simulated heat wave exposure in older individuals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will spend 3-hours in a heat chamber at 41°C and 40% humidity.
Time frame: Continuously throughout the 3-hour heat exposure.
The change in internal temperature to the 3-hour heat exposure will be measured.
Time frame: Nude body mass will be measured before and after the 3-hour heat exposure.
Whole body sweat rate will be measured via changes in pre/post nude body mass.
Time frame: Continuously throughout the 3-hour heat exposure.
Heart rate will be measured via electrocardiogram.
Time frame: Continuously throughout the 3-hour heat exposure.
Systolic and diastolic arterial blood pressures will be measured via a brachial blood pressure cuff.
Contact information is provided by the study sponsor or research team.
Courtney Kirby, RN
CONTACT
Erin Harper, MS
CONTACT
University of Texas Southwestern Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06842784
Aging, Body Temperature Changes
Dallas, Texas, United States
View Trial DetailsNCT07032493
Aging, Body Temperature Changes
Ottawa, Ontario, Canada
View Trial DetailsNCT06142890
Aging, Body Temperature Changes
Ottawa, Ontario, Canada
View Trial DetailsNCT05838612
Aging, Body Temperature Changes
Ottawa, Ontario, Canada
View Trial Details